Citation Impact
Citing Papers
G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway
2009 StandoutNobel
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
“Selective” serotonin 5-HT2A receptor antagonists
2022
Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice
2015
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
Similarity in drugs: reflections on analogue design
2006
Molecular biology of α-adrenergic receptors: implications for receptor classification and for structure-function relationships
1991 StandoutNobel
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double‐blind parallel‐group trial
1995
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography
1993
G Protein-Coupled Receptor Kinase Function Is Essential for Chemosensation in C. elegans
2004 StandoutNobel
Risperidone versus haloperidol: I. meta-analysis of efficacy and safety
1998
Estrogen control of central neurotransmission: Effect on mood, mental state, and memory
1996
Imidazolones in Diastereoselective Cyclization Reactions and CuII‐Catalysed Cross‐Coupling Reactions
2009 StandoutNobel
Functional study of rat 5‐HT2A receptors using antisense oligonucleotides
2003
Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
2005
Mechanisms of action of atypical antipsychotic drugs
1991
5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions
1993
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling
2006 StandoutNobel
Polypharmacology of dopamine receptor ligands
2016
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine?s actions?
2004
Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage
1990
DOPAMINERGIC SYSTEMS
1997
Levocabastine: Pharmacological profile of a highly effective inhibitor of allergic reactions
1992
Recent advances in transition-metal-free carbon–carbon and carbon–heteroatom bond-forming reactions using arynes
2012 Standout
Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens
1996
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Efficient Solid‐Phase Synthesis of Peptide‐Based Phosphine Ligands: Towards Combinatorial Libraries of Selective Transition Metal Catalysts
2005 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
1990 Nature
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The Serotonin Syndrome
2005 Standout
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
1999 Standout
Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat
1996
The dopamine D4 receptor: biochemical and signalling properties
2010
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
Amino acid derived 1,4‐dialkyl substituted imidazolones
2010 StandoutNobel
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
1996
The neural basis of psychedelic action
2022 Standout
The pharmacology of α1- and α2-adrenoceptors: Evidence for and against a further subdivision
1989
Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis
1999 Standout
Relating protein pharmacology by ligand chemistry
2007 Standout
Psychiatric Aspects of Impulsivity
2001 Standout
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
A Double-Blind Pilot Study of Risperidone in the Treatment of Conduct Disorder
2000
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Solid‐Phase Synthesis of Tetrahydro‐β‐carbolines and Tetrahydroisoquinolines by Stereoselective Intramolecular N‐Carbamyliminium Pictet–Spengler Reactions
2006 StandoutNobel
FeCl3-catalyzed synthesis of functionally diverse dibenzo[b,f]oxepines and benzo[b]oxepines via alkyne–aldehyde metathesis
2013
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
1991 StandoutNature
Estrogen Actions in the Central Nervous System1
1999 Standout
Iron Catalysis in Organic Synthesis
2015 Standout
Synthesis of Dibenzoxepine Lactams via a Cu-Catalyzed One-Pot Etherification/Aldol Condensation Cascade Reaction: Application toward the Total Synthesis of Aristoyagonine
2013
Estrogen increases the density of 5-Hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat
1995
Synthesis of Benzisoxazoles by the [3 + 2] Cycloaddition ofin situGenerated Nitrile Oxides and Arynes
2010
Diversity‐Oriented Syntheses by Combining CuAAC and Stereoselective INCIC Reactions with Peptides
2017 StandoutNobel
Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
1994 StandoutNobel
Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor
1992 StandoutScience
Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: Blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist
1994
Synthesis of 3‐Boc‐(1,3)‐oxazinane‐Protected Amino Aldehydes from Amino Acids and Their Conversion into Urea Precursors. Novel Building Blocks for Combinatorial Synthesis
2004 StandoutNobel
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
2003 StandoutNobel
Theoretical Studies on N–O or N–N Bond Formation from Aryl Azide Catalyzed by Iron(II) Bromide Complex
2012
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
The paradox of α2 adrenergic regulation of prolactin (PRL) secretion. I. the PRL-releasing action of the α2 receptor agonists
1989
Advances in Synthetic Applications of Hypervalent Iodine Compounds
2016 Standout
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Following the trace of elusive amines
2001
Serotonin receptor knockouts: A moody subject
1998 StandoutNobel
‘On-water’ synthesis of chromeno-isoxazoles mediated by [hydroxy(tosyloxy)iodo]benzene (HTIB)
2010
Sila-Trifluperidol, a Silicon Analogue of the Dopamine (D2) Receptor Antagonist Trifluperidol: Synthesis and Pharmacological Characterization
2010
Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds: Synthetic Routes, Properties, and Applications
2016 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Works of Anton Megens being referenced
Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol
1988
Does phenylethylamine act as an endogenous amphetamine in some patients?
1999
Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and α2-adrenoceptor antagonistic activities: a novel series of potential antidepressants
2003
5 Risperidone and related 5HT2/D2 antagonists: A new type of antipsychotic agent?
1996
Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors
2002
Behavioural activity of rats measured by a new method based on the piezo-electric principle
1987
Interaction of haloperidol and risperidone (R 64 766) with amphetamine‐induced motility changes in rats
1989
Gavage-Related Reflux in Rats
2010
Further validation of in vivo and in vitro pharmacological procedures for assessing the α2/α1-selectivity of test compounds: (1) α-adrenoceptor antagonists
1986
Further validation of in vivo and in vitro pharmacological procedures for assessing the α2/α1-selectivity of test compounds: (2) α-adrenoceptor agonists
1986
Synthesis of 2-N,N-Dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo-[b,f]furo[2,3-d]oxepin Derivatives as Potential Anxiolytic Agents
2004
Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with α2-Adrenoceptor Blocking Activity
2004
Discovery of New Tetracyclic Tetrahydrofuran Derivatives as Potential Broad-Spectrum Psychotropic Agents
2004
Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
1988